Serum amyloid protein: Difference between revisions
From WikiLectures
No edit summary |
|||
| Line 4: | Line 4: | ||
It is involved in the formation of amyloid deposits, where as a coprecipitated component it constitutes 5-15% of the amyloid mass. Radiolabelled SAP can be used to determine the extent of involvement in amyloidosis. | It is involved in the formation of amyloid deposits, where as a coprecipitated component it constitutes 5-15% of the amyloid mass. Radiolabelled SAP can be used to determine the extent of involvement in amyloidosis. | ||
==Links== | ==Links== | ||
=== | ===Related articles=== | ||
*[[Amyloidosis]] | *[[Amyloidosis]] | ||
*[[Serum amyloid A]] | *[[Serum amyloid A]] | ||
*[[Acute phase reactants]] | *[[Acute phase reactants]] | ||
Latest revision as of 21:01, 4 April 2022
Serum amyloid protein is an acute phase reactant that is synthesized in the liver and degraded there. Its physiological function is to protect chromatin from the action of the immune system.
It is involved in the formation of amyloid deposits, where as a coprecipitated component it constitutes 5-15% of the amyloid mass. Radiolabelled SAP can be used to determine the extent of involvement in amyloidosis.
